Guohui Cui - Search Results

Year	Number of Results
2003	1
2004	5
2005	4
2006	7
2007	10
2008	10
2009	5
2011	3
2012	11
2013	1
2014	4
2015	4
2016	3
2017	2
2019	1
2020	1
2021	5
2022	5
2023	6
2024	0

1

Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System.

Saw PE, Cui GH, Xu X. Saw PE, et al. ChemMedChem. 2022 May 4;17(9):e202100777. doi: 10.1002/cmdc.202100777. Epub 2022 Mar 25. ChemMedChem. 2022. PMID: 35261159 Review.

2

Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer.

Wu L, Bai S, Huang J, Cui G, Li Q, Wang J, Du X, Fu W, Li C, Wei W, Lin H, Luo ML. Wu L, et al. Among authors: cui g. Cancers (Basel). 2023 Jun 16;15(12):3221. doi: 10.3390/cancers15123221. Cancers (Basel). 2023. PMID: 37370831 Free PMC article.

3

Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study.

Cao XX, Jin J, Fu CC, Yi SH, Zhao WL, Sun ZM, Yang W, Li DJ, Cui GH, Hu JD, Liu T, Song YP, Xu B, Zhu ZM, Xu W, Zhang MZ, Tian YM, Zhang B, Zhao RB, Zhou DB. Cao XX, et al. EClinicalMedicine. 2022 Oct 4;52:101682. doi: 10.1016/j.eclinm.2022.101682. eCollection 2022 Oct. EClinicalMedicine. 2022. PMID: 36313145 Free PMC article.

4

Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study.

Zhong H, Cheng S, Zhang X, Xu B, Chen J, Jiang X, Xiong J, Hu Y, Cui G, Wei J, Qian W, Huang X, Hou M, Yan F, Wang X, Song Y, Hu J, Liu Y, Ma X, Li F, Wu C, Chen J, Yu L, Bai O, Xu J, Zhu Z, Liu L, Zhou X, Huang L, Tong Y, Niu T, Wu D, Zhang H, Wang C, Ouyang B, Yi H, Song Q, Cai G, Li B, Liu J, Li Z, Xiao R, Wang L, Jiang Y, Liu Y, Zheng X, Xu P, Huang H, Wang L, Chen S, Zhao W. Zhong H, et al. Among authors: cui g. Innovation (Camb). 2023 Apr 13;4(3):100426. doi: 10.1016/j.xinn.2023.100426. eCollection 2023 May 15. Innovation (Camb). 2023. PMID: 37181228 Free PMC article.

5

Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial.

Liang J, Wang L, Wang X, Cui G, Zhou J, Xing T, Du K, Xu J, Wang L, Liang R, Chen B, Cheng J, Shen H, Li J, Xu W. Liang J, et al. Among authors: cui g. Chin Med J (Engl). 2023 Oct 13. doi: 10.1097/CM9.0000000000002836. Online ahead of print. Chin Med J (Engl). 2023. PMID: 37839894

6

[Correlation of PI3K-Akt signal pathway to apoptosis of tumor cells].

Huang XL, Cui GH, Zhou KY. Huang XL, et al. Ai Zheng. 2008 Mar;27(3):331-6. Ai Zheng. 2008. PMID: 18334129 Free article. Review. Chinese.

7

Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils.

Zhou Z, Zhao Y, Chen S, Cui G, Fu W, Li S, Lin X, Hu H. Zhou Z, et al. Among authors: cui g. Front Pharmacol. 2022 Jun 13;13:870178. doi: 10.3389/fphar.2022.870178. eCollection 2022. Front Pharmacol. 2022. PMID: 35784745 Free PMC article.

8

MiR196a-5p in extracellular vesicles released from human nasopharyngeal carcinoma enhance the phagocytosis and secretion of microglia by targeting ROCK1.

Chen P, Liu R, Yu Z, Cui G, Zong W, Wang M, Xie M, Qu W, Wang W, Luo X. Chen P, et al. Among authors: cui g. Exp Cell Res. 2022 Feb 15;411(2):112988. doi: 10.1016/j.yexcr.2021.112988. Epub 2021 Dec 21. Exp Cell Res. 2022. PMID: 34951996

9

Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer.

Li S, Feng J, Weng H, Zhao F, Cui G, Fu W, Lin X, Hu H. Li S, et al. Among authors: cui g. Cancer Manag Res. 2022 Sep 22;14:2871-2884. doi: 10.2147/CMAR.S382079. eCollection 2022. Cancer Manag Res. 2022. PMID: 36171861 Free PMC article.

10

Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.

Wang S, Wang L, Hu J, Qian W, Zhang X, Hu Y, Zhu Q, Chen B, Wu D, Chang CH, Xu P, Zheng X, Wei J, Liu Y, Cui G, Tang Y, Ma Y, Huang H, Yi H, Zhao W. Wang S, et al. Among authors: cui g. Cancer Commun (Lond). 2021 Mar;41(3):229-239. doi: 10.1002/cac2.12126. Epub 2021 Jan 22. Cancer Commun (Lond). 2021. PMID: 33482051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year